QNCX icon

Quince Therapeutics
QNCX

Overview Fund Activity

40 hedge funds and large institutions have $13.5M invested in Quince Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 9 closing their positions.

Holders
40
Holders Change
-5
Holders Change %
-11.11%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
10
Closed
9
Calls
$167K
Puts
$2K
Net Calls
+$165K
Net Calls Change
-$189K

Top Buyers

1
BCM
1
BML Capital Management
Indiana
$2.12M
2
KAM
2
Knightsbridge Asset Management
California
$344K
3
Bank of America
3
Bank of America
North Carolina
$245K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$434K
5
IP
5
Intellectus Partners
California
$80.6K

Top Sellers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$288K
2
Millennium Management
2
Millennium Management
New York
$92.4K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$105K
4
BCM
4
Bridgeway Capital Management
Texas
$82.8K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
51
Simplex Trading
Illinois
– – – –
Wolverine Trading
52
Wolverine Trading
Illinois
– – – –
Group One Trading
53
Group One Trading
Illinois
– – – –
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
Barclays
55
Barclays
United Kingdom
$0 100 – –
1 2
3